LA Private

Uncategorized

Afternoon update: ASX up 0.18%: China’s offical manufacturing index falls

The S&P/ASX 200 is trading 0.18 per cent higher at 6,785.30. Futures The SPI futures are up 12 points. Best and worst performers The best-performing sector is REITs, up 1.56 per cent. The worst-performing sector is Materials, down 1.09 per cent. The best-performing large cap is Qantas Airways (ASX:QAN), trading 3.13 per cent higher at […]

Afternoon update: ASX up 0.18%: China’s offical manufacturing index falls Read More »

Stocks of the Hour: Chimeric Therapeutics, Power Minerals, James Bay Minerals

Chimeric Therapeutics (ASX:CHM), announced that the FDA has cleared the Investigational New Drug application of CHM 2101, Chimeric’s first in class CDH17 CAR T cell therapy for gastrointestinal cancers.  Michael R. Bishop, Professor of Medicine and Director at the University of Chicago commented “I am really excited about the planned Phase 1 clinical trial of

Stocks of the Hour: Chimeric Therapeutics, Power Minerals, James Bay Minerals Read More »

Immutep (ASX:IMM) reports 71.4% response rate for lung cancer therapy

Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses progress of the company’s drug candidates, highlighting promising data from the  2023 ESMO Congress. Paul Sanger: I’m Paul Sanger for the Finance News Network, and today we’re talking with Immutep (ASX:IMM), and they have a market cap of $380m. Immutep is a clinical-stage biotech company

Immutep (ASX:IMM) reports 71.4% response rate for lung cancer therapy Read More »

US Fed holds steady

Even though the economy is booming and job growth continues, inflation is slowing, leading the US Federal Reserve to refrain from raising interest rates this week. The Fed’s favored PCE inflation reading for September saw a slight increase, but rates are expected to remain unchanged after the two-day meeting early Thursday morning, Sydney time. There’s

US Fed holds steady Read More »